ACC: New module to collect data on CV complications of COVID-19
Using the National Cardiovascular Data Registry Chest Pain-MI and CathPCI registries, the American College of Cardiology will begin collecting data with the aim of discerning the relationship between the COVID-19 and heart disease.
According to a press release issued by the ACC, hospitals already participating in these registries will have the first opportunity to add data on patients with COVID-19 , beginning with the earliest cases in the U.S.
Institutions will add to the new data module information on the COVID-19 status of all enrolled patients; assess biomarkers that may indicate CV injury in patients with COVID-19; monitor events that occurred during hospitalization that may reflect cardiac complications of COVID-19 and the associated therapies.
“Registries will play a key role in understanding how this virus influences the care and outcomes for individuals with heart disease, both now and in the future,” Frederick Masoudi, MD, MSPH, FACC, management board chair and chief scientific adviser for the NCDR and professor of medicine (cardiology) at the University of Colorado School of Medicine, said in the release. “We already collect high-quality clinical data to support hospitals in providing the highest quality care. Now it is critical to collect additional data that will provide key insights on the quality of care and outcomes of heart disease patients in the COVID-19 era.”
In addition, long-term registry data will provide insight on the racial, ethnic and gender group impacts of COVID-19 and identify disparities in care, according to the release.
“The ACC remains committed to helping its members continue to transform cardiovascular care and improve heart health.” Athena Poppas, MD, FACC, FASE, president of the ACC and chief of the cardiology division, director of the Lifespan Cardiovascular Institute and director of echocardiography at Rhode Island, The Miriam and Newport Hospitals, said in the release. “We are learning every day how COVID-19 impacts our patients. By adapting our registries to answer pressing scientific questions and knowledge gaps, we can ensure that our cardiovascular care team has validated data and updated tools to provide the highest quality care particularly during these uncertain times.”
Disclosures: Masoudi and Poppas report no relevant financial disclosures.
Collapse
Read more from COVID-19 Resource Center
View all
Read more about